DocuSign, Inc. (DOCU) Guidance & Earnings Results
On 2026-09-03 DocuSign, Inc. raised guidance: "Q3 FY2027 revenue $886-890M; FY2027 revenue $3,499-3,507M; FY2027 ARR growth 8.5-9.0%; Q3 FY2027 non-GAAP gross margin 81.5-81.9%; FY2027 non-GAAP gross margin 81.5-82.0%; Q3 FY2027 non-GAAP operating margin 31.3-31.7%;…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
DOCUDocuSign, Inc.Follow DOCU — free
—
Price chart with a free account
- Market cap
- 15.9B
- P/E TTM
- 52.0
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Dec, in 38 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 3 Sep 26 | Raised | Q3 FY2027 revenue $886-890M; FY2027 revenue $3,499-3,507M; FY2027 ARR growth 8.5-9.0%; Q3 FY2027 non-GAAP gross margin 81.5-81.9%; FY2027 non-GAAP gross margin 81.5-82.0%; Q3 FY2027 non-GAAP operating margin 31.3-31.7%; FY2027 non-GAAP operating margin 31.0-31.5%; IAM expected to be 18-19% of total ARR exiting Q4 FY2027 |
| 4 Jun 26 | Raised | Q2 FY2027 revenue $865-869M (8% YoY), FY2027 revenue $3,490-3,502M (9% YoY), ARR growth 8.25-8.75% |
| 4 Dec 25 | Raised | FY26 revenue guidance raised to $3.208-3.212B (8% YoY midpoint); subscription revenue $3.140-3.144B (8% YoY); billings $3.379-3.389B (9% YoY) · full year |
DocuSign, Inc. — questions
- What guidance did DocuSign, Inc. give?
- On 2026-09-03: "Q3 FY2027 revenue $886-890M; FY2027 revenue $3,499-3,507M; FY2027 ARR growth 8.5-9.0%; Q3 FY2027 non-GAAP gross margin 81.5-81.9%; FY2027 non-GAAP gross margin 81.5-82.0%; Q3 FY2027 non-GAAP operating margin 31.3-31.7%; FY2027 non-GAAP operating margin 31.0-31.5%; IAM expected to be 18-19% of total "
- When does DocuSign, Inc. report earnings?
- DocuSign, Inc.'s next earnings report is expected on 2026-12-02.
Every figure on this page comes from DocuSign, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.